Stifel raises Edwards Lifesciences stock to buy
Edwards SAPIEN XT Transcatheter Heart Valve ... If both a cardiovascular surgeon and cardiologist determine that you are to high risk for standard aortic valve replacement (AVR), then ...
Edwards Lifesciences' Business In-Depth ... Its products and technologies are grouped into four main areas: Transcatheter Aortic Valve Replacement (TAVR): Comprised 64.6% of total revenues in ...
Edwards Lifesciences introduced TAVR to ... largely because of poor sales growth for U.S. transcatheter aortic valve replacement procedures. Third quarter U.S. TAVI sales of $55 million were ...
Wolfe Research downgraded Edwards Lifesciences (EW) to Underperform from Peer Perform with a $60 price target The firm says its core ...
GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”) ...
These techniques include coronary sinus annuloplasty, direct annuloplasty, leaflet repair ... (Edwards Lifesciences, Inc., CA, USA) valve is a balloon-expandable, bovine pericardial ...